BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.260
+0.030 (1.35%)
Feb 13, 2026, 5:35 PM CET
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €49.38 million as of February 13, 2026. Its market cap has decreased by -23.91% in one year.
Market Cap
49.38M
Enterprise Value
63.79M
Revenue
50.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.26
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 49.38M, a decrease of -66.94%. That is a compound annual growth rate of -10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 49.38M | -10.32% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brenntag SE | 8.41B |
| Evonik Industries AG | 7.39B |
| Wacker Chemie AG | 4.00B |
| LANXESS Aktiengesellschaft | 1.84B |
| Verbio SE | 1.54B |
| AlzChem Group AG | 1.47B |
| Uzin Utz SE | 416.16M |
| H&R GmbH & Co. KGaA | 164.15M |